top of page
Sep 26

Houston Oncology Summit: MD Anderson Professor of Immunology Michael Curran talks turning cold tumors hot, including work by his company ImmunoGenesis

He discusses pathways that could play a role in helping solve this problem, including combinations with ADCs, STING and CD47, and work by his company ImmunoGenesis on a PD-L1/PD-L2 inhibitor



Brought to you by:



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

@BiotechTVHQ

BiotechTV

BiotechTVHQ

@BiotechTV

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

KH_Logo_Horizontal_Tagline_Black-1.png

Klein Hersh is a precision executive search firm with over 25 years of proven success partnering with clients to deliver the visionary leaders shaping the future of life sciences and healthcare. We believe that the innovation behind a healthier world starts with bringing the best and brightest minds together. Our experienced team of dedicated experts is deeply immersed in every facet of pharma, biotech, and healthcare, and has developed trusted relationships with far-reaching talent networks.

Visit Klein Hersh

bottom of page